IWM: Do Small Caps Have Small Hopes?
On Friday's airing of Options Action, the Chart Master Carter Braxton Worth took a sharper eye to small-cap stocks. The Russell 2000 is the benchmark index that both professional and…
WEN: Wendy’s… Where’s the Beef?
Anyone who owned Wendys going into the COVID strike had a heart attack as the stock plummeted. Sellers were fearful that the lockdown would send sales to zero or nearly…
How U.S. Consumers are Spending Their $$$ During the COVID-19 Lockdown
In 2019, nearly 70% of U.S. GDP was driven by personal consumption. However, in the first quarter of 2020, the COVID-19 pandemic has initiated a transformation of consumer spending trends as…
Close SPY Hedge & TSLA Short Vol Trades
Today, we suggest investors close a couple of trades. The SPY trade was a hedge/bearish bet that did not work. The other is a Tesla trade that worked magnificently. This…
How COVID-19 Has Impacted Media Consumption, by Generation
As the coronavirus outbreak continues to wreak havoc across the globe, people’s time that would have otherwise been spent perusing malls or going to live events is now being spent…
MRVL: Marvelous or Lethargic?
Carter Braxton Worth took aim at a Marvel Technology Group (MRVL) during Friday nights (22-May-2020) episode of Options Action. MRVL is an interesting semiconductor company whose stock has lagged for…
NVDA: NVIDIA as Good as it Gets?
NVIDIA is a producer of video chips, and it is one of the best microchip companies in the business. Their products are used in computers for traditional graphics and virtual…
TDOC: Trade Adjustment on Teledoc
Back on April 22, we suggested investors and traders take a look at Teledoc (TDOC). This company is one of those names that fall into the category of a COVID-19…
FDX: Federal Express, The Final Washout
Federal Express represents an exciting story. The company has had its strategic / management / operational issues, and investors have taken the company's stock "to task" as a result. But…
SCHW: Trade Update
Schwab had a bit of a rally on the back of a Corona vaccine story. But this does not change the fundamental and economic backdrop under which this company must…